Announcements
- Conduit Pharmaceuticals Receives Patent Approval For Its Lead Asset Targeting Autoimmune Diseases
- Conduit Pharmaceuticals to Join Russell 3000® Index
- Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer
- Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe’s Leading Life Sciences Hub
- Conduit Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
- Conduit Pharmaceuticals to Participate in the 14th Annual Jefferies London Healthcare Conference
- Conduit Pharmaceuticals Partners with ClinConnect on Cocrystal Development Program for AZD1656
More ▼
Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | -- |
Average volume | -- |
---|---|
Shares outstanding | 73.83m |
Free float | 9.85m |
P/E (TTM) | -- |
Market cap | 19.45m USD |
EPS (TTM) | -0.0339 USD |
--
More ▼